Dynavax Technologies
DVAX
#4927
Rank
โ‚ฌ1.53 B
Marketcap
13,06ย โ‚ฌ
Share price
0.03%
Change (1 day)
2.58%
Change (1 year)

Market capitalization of Dynavax Technologies (DVAX)

Market cap: โ‚ฌ1.53 Billion

As of February 2026 Dynavax Technologies has a market cap of โ‚ฌ1.53 Billion. This makes Dynavax Technologies the world's 4927th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Dynavax Technologies from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ1.53 B-0.22%
2025โ‚ฌ1.53 B-6.38%
2024โ‚ฌ1.64 B0.46%
2023โ‚ฌ1.63 B29.17%
2022โ‚ฌ1.26 B-15.08%
2021โ‚ฌ1.49 B273.82%
2020โ‚ฌ0.39 B-6.91%
2019โ‚ฌ0.42 B-14.82%
2018โ‚ฌ0.50 B-46.76%
2017โ‚ฌ0.94 B552.75%
2016โ‚ฌ0.14 B-82.97%
2015โ‚ฌ0.84 B132.94%
2014โ‚ฌ0.36 B-2.22%
2013โ‚ฌ0.37 B-5.3%
2012โ‚ฌ0.39 B21.49%
2011โ‚ฌ0.32 B16.56%
2010โ‚ฌ0.27 B417%
2009โ‚ฌ53.79 M124.66%
2008โ‚ฌ23.94 M-82.79%
2007โ‚ฌ0.13 B-49.63%
2006โ‚ฌ0.27 B228.41%
2005โ‚ฌ84.13 M-39.74%
2004โ‚ฌ0.13 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Dynavax Technologies was reported to be:

โ‚ฌ1.53 Billion
by Nasdaq info icon info icon
โ‚ฌ1.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
โ‚ฌ126.81 B 8,167.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ155.30 B 10,024.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ22.26 B 1,351.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ148.58 B 9,586.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ232.35 B 15,047.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ242.65 B 15,718.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ87.97 B 5,635.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
โ‚ฌ86.58 M-94.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ32.98 B 2,050.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel